Samantha Exner
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: November 14, 2022
Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: March 24, 2022
SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model.
Journal: Frontiers in oncology
Published: March 23, 2021
A Cyanine-Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation.
Journal: Chembiochem : a European journal of chemical biology
Published: November 23, 2020
AGTR1 Is Overexpressed in Neuroendocrine Neoplasms, Regulates Secretion and May Potentially Serve as a Target for Molecular Imaging and Therapy.
Journal: Cancers
Published: October 06, 2020
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo.
Journal: Neoplasia (New York, N.Y.)
Published: September 07, 2020
mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms.
Journal: Frontiers in oncology
Published: June 30, 2020
Multimodal Imaging of 2-Cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 27, 2020
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
Journal: Theranostics
Published: March 13, 2019
Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.
Journal: PloS one
Published: February 06, 2019
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines.
Journal: Frontiers in endocrinology
Published: January 09, 2018
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
Journal: PloS one
Published: April 11, 2017
Last Updated: 09/26/2026